Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Trials ; 25(1): 445, 2024 Jul 03.
Article in English | MEDLINE | ID: mdl-38961505

ABSTRACT

BACKGROUND: Body weight loss (BWL) after gastrectomy impact on the short- and long-term outcomes. Oral nutritional supplement (ONS) has potential to prevent BWL in patients after gastrectomy. However, there is no consistent evidence supporting the beneficial effects of ONS on BWL, muscle strength and health-related quality of life (HRQoL). This study aimed to evaluate the effects of ONS formulated primarily with carbohydrate and protein on BWL, muscle strength, and HRQoL. METHODS: This will be a multicenter, open-label, parallel, randomized controlled trial in patients with gastric cancer who will undergo gastrectomy. A total of 120 patients who will undergo gastrectomy will be randomly assigned to the ONS group or usual care (control) group in a 1:1 ratio. The stratification factors will be the clinical stage (I or ≥ II) and surgical procedures (total gastrectomy or other procedure). In the ONS group, the patients will receive 400 kcal (400 ml)/day of ONS from postoperative day 5 to 7, and the intervention will continue postoperatively for 8 weeks. The control group patients will be given a regular diet. The primary outcome will be the percentage of BWL (%BWL) from baseline to 8 weeks postoperatively. The secondary outcomes will be muscle strength (handgrip strength), HRQoL (EORTC QLQ-C30, QLQ-OG25, EQ-5D-5L), nutritional status (hemoglobin, lymphocyte count, albumin), and dietary intake. All analyses will be performed on an intention-to-treat basis. DISCUSSION: This study will provide evidence showing whether or not ONS with simple nutritional ingredients can improve patient adherence and HRQoL by reducing BWL after gastrectomy. If supported by the study results, nutritional support with simple nutrients will be recommended to patients after gastrectomy for gastric cancer. TRIAL REGISTRATION: jRCTs051230012; Japan Registry of Clinical Trails. Registered on Apr. 13, 2023.


Subject(s)
Dietary Supplements , Gastrectomy , Multicenter Studies as Topic , Quality of Life , Randomized Controlled Trials as Topic , Stomach Neoplasms , Humans , Stomach Neoplasms/surgery , Gastrectomy/adverse effects , Treatment Outcome , Weight Loss , Administration, Oral , Middle Aged , Male , Female , Adult , Aged , Nutritional Status , Time Factors , Hand Strength , Muscle Strength
2.
Asian J Endosc Surg ; 16(4): 809-813, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37394285

ABSTRACT

INTRODUCTION: The therapeutic strategy for superficial nonampullary duodenal epithelial tumors remains controversial. We developed a novel surgical technique for superficial nonampullary duodenal epithelial tumors. We report the initial two cases managed with this method. MATERIALS AND SURGICAL TECHNIQUE: We endoscopically confirmed the tumor location and circumferentially incised the seromuscular layer of the duodenum along it. After circumferential seromyotomy, the submucosal layer was expanded by endoscopic insufflation, and the target lesion was sufficiently lifted. The submucosal layer, including the target lesion, was stapled and resected after confirming the absence of problems with endoscopic passage. The seromuscular layer was continuously sutured to bury and reinforce the stapler line. Single-incision laparoscopic surgery was performed in one case. The resected specimens measured 52 × 32 mm and 50 × 26 mm with negative surgical margins. Both patients were discharged without complications and demonstrated no evidence of stenosis. DISCUSSION: Compared with previously reported procedures, this method of partial duodenectomy with seromyotomy for superficial nonampullary duodenal epithelial tumors is promising, simple, and safe.


Subject(s)
Carcinoma , Digestive System Surgical Procedures , Duodenal Neoplasms , Laparoscopy , Humans , Duodenum/surgery , Duodenal Neoplasms/surgery , Duodenal Neoplasms/pathology , Laparoscopy/methods , Carcinoma/pathology
4.
Ann Med Surg (Lond) ; 85(2): 266-270, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36845766

ABSTRACT

Diffusely infiltrative squamous cell carcinoma of the esophagus is rare and difficult to diagnose. Case presentation: The patient was a 75-year-old woman whose chief complaints were dysphagia and upper abdominal pain. Esophagogastroduodenoscopy and biopsy revealed squamous cell carcinoma at the abdominal esophagus. After neoadjuvant chemotherapy, esophagogastroduodenoscopy showed diffuse thickening and poor distensibility of the stomach wall. We suspected scirrhous gastric cancer and performed multiple biopsies, which revealed no evidence of malignancy. We then performed staging laparoscopy. There were no apparent changes in the serous membrane of the stomach, but peritoneal lavage cytology revealed squamous cell carcinoma. Thus, we made a diagnosis of squamous cell carcinoma of the esophagus with diffuse invasion of the stomach. Intraoperative pathological diagnosis revealed that there was greater diffuse submucosal invasion of the oral esophagus than we expected, and we had to resect the esophagus at the level of the middle thoracic esophagus. Despite multidisciplinary treatment (surgery, chemotherapy, and radiotherapy), the patient died 20 months after the initial diagnosis. Clinical discussion: In this case, although biopsy did not lead to a diagnosis, peritoneal lavage cytology led to the correct diagnosis. Moreover, it was impossible to preoperatively predict the exact extent of the expansion because of diffuse submucosal invasion. Conclusion: When diffusely infiltrative squamous cell carcinoma of the esophagus is suspected, peritoneal lavage cytology may be useful for confirming the diagnosis; however, it should be assumed that accurate preoperative evaluation of the range of diffusely infiltrative squamous cell carcinoma is difficult.

5.
Ann Surg Oncol ; 30(6): 3605-3614, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36808589

ABSTRACT

BACKGROUND: Despite growing evidence of the effectiveness of minimally invasive surgery (MIS) for primary gastric cancer, MIS for remnant gastric cancer (RGC) remains controversial due to the rarity of the disease. This study aimed to evaluate the surgical and oncological outcomes of MIS for radical resection of RGC. PATIENTS AND METHODS: Patients with RGC who underwent surgery between 2005 and 2020 at 17 institutions were included, and a propensity score matching analysis was performed to compare the short- and long-term outcomes of MIS with open surgery. RESULTS: A total of 327 patients were included in this study and 186 patients were analyzed after matching. The risk ratios for overall and severe complications were 0.76 [95% confidence interval (CI): 0.45, 1.27] and 0.65 (95% CI: 0.32, 1.29), respectively. The MIS group had significantly less blood loss [mean difference (MD), -409 mL; 95% CI: -538, -281] and a shorter hospital stay (MD, -6.5 days; 95% CI: -13.1, 0.1) than the open surgery group. The median follow-up duration of this cohort was 4.6 years, and the 3-year overall survival were 77.9% and 76.2% in the MIS and open surgery groups, respectively [hazard ratio (HR), 0.78; 95% CI: 0.45, 1.36]. The 3-year relapse-free survival were 71.9% and 62.2% in the MIS and open surgery groups, respectively (HR, 0.71; 95% CI: 0.44, 1.16). CONCLUSIONS: MIS for RGC showed favorable short- and long-term outcomes compared to open surgery. MIS is a promising option for radical surgery for RGC.


Subject(s)
Stomach Neoplasms , Humans , Retrospective Studies , Stomach Neoplasms/surgery , Neoplasm Recurrence, Local/surgery , Cohort Studies , Minimally Invasive Surgical Procedures , Length of Stay , Treatment Outcome
6.
Gastric Cancer ; 25(4): 817-826, 2022 07.
Article in English | MEDLINE | ID: mdl-35416523

ABSTRACT

BACKGROUND: The safety of robotic gastrectomy (RG) for gastric cancer in daily clinical settings and the process by which surgeons are introduced and taught RG remain unclear. This study aimed to evaluate the safety of RG in daily clinical practice and assess the learning process in surgeons introduced to RG. METHODS: Patients who underwent RG for gastric cancer at Kyoto University and 12 affiliated hospitals across Japan from January 2017 to October 2019 were included. Any morbidity with a Clavien-Dindo classification grade of II or higher was evaluated. Moreover, the influence of the surgeon's accumulated RG experience on surgical outcomes and surgeon-reported postoperative fatigue were assessed. RESULTS: A total of 336 patients were included in this study. No conversion to open or laparoscopic surgery and no in-hospital mortality were observed. Overall, 50 (14.9%) patients developed morbidity. During the study period, 14 surgeons were introduced to robotic procedures. The initial five cases had surprisingly lower incidence of morbidity compared to the following cases (odds ratio 0.29), although their operative time was longer (+ 74.2 min) and surgeon's fatigue scores were higher (+ 18.4 out of 100 in visual analog scale). CONCLUSIONS: RG was safely performed in actual clinical settings. Although the initial case series had longer operative time and promoted greater levels of surgeon fatigue compared to subsequent cases, our results suggested that RG had been introduced safely.


Subject(s)
Laparoscopy , Robotic Surgical Procedures , Stomach Neoplasms , Cohort Studies , Gastrectomy/adverse effects , Gastrectomy/methods , Humans , Laparoscopy/adverse effects , Laparoscopy/methods , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/surgery , Retrospective Studies , Robotic Surgical Procedures/adverse effects , Robotic Surgical Procedures/methods , Treatment Outcome
7.
Gan To Kagaku Ryoho ; 49(13): 2001-2003, 2022 Dec.
Article in Japanese | MEDLINE | ID: mdl-36733071

ABSTRACT

A 68-year-old man with dysphagia had advanced esophageal cancer with single liver metastasis(cT4bN2M1, cStage Ⅳb). After induction chemoradiotherapy, consisting of 2 courses of FP therapy and 40 Gy radiotherapy, thoracoscopic radical esophagectomy and laparoscopic partial resection of liver metastatic lesion were performed because the primary lesion was significantly reduced. Histopathological findings showed that the therapeutic effect of the primary lesion was Grade 3, and lymph node metastasis and liver metastasis disappeared, resulting in pathological CR. Postoperative chemotherapy was not performed. Esophageal cancer did not recur during 3 and a half years after the operation.


Subject(s)
Esophageal Neoplasms , Liver Neoplasms , Male , Humans , Aged , Neoplasm Recurrence, Local/surgery , Esophageal Neoplasms/pathology , Chemoradiotherapy , Liver Neoplasms/secondary , Esophagectomy/methods , Antineoplastic Combined Chemotherapy Protocols/therapeutic use
8.
Ann Surg Open ; 2(2): e063, 2021 Jun.
Article in English | MEDLINE | ID: mdl-37636555

ABSTRACT

Objective: A multicenter retrospective cohort study was performed to compare the outcomes of laparoscopic gastrectomy (LG) versus open gastrectomy (OG) for scirrhous gastric cancer (GC) as a unique subtype also known as type 4 gastric cancer or linitis plastica. Background: Although data on the efficacy and safety of LG as an alternative to OG are emerging, the applicability of LG to scirrhous GC remains unclear. Methods: Patients with clinical type 4 GC undergoing gastrectomy at 13 hospitals from 2005 to 2015 were retrospectively reviewed. As the primary endpoint, we compared overall survival (OS) between the LG and OG groups. To adjust for confounding factors, we used multivariate Cox regression analysis for the main analyses and propensity-score matching for sensitivity analysis. Short-term outcomes and recurrence-free survival were also compared. Results: A total of 288 patients (LG, 62; OG, 226) were included in the main analysis. Postoperative complications occurred in 25.8% and 30.1%, respectively (P = 0.44). No significant difference in recurrence-free survival was observed (P = 0.72). The 5-year OS rates were 32.4% and 31.6% in the LG and OG groups, respectively (P = 0.60). The hazard ratio (LG/OG) for OS was 0.98 (95% confidence interval [CI], 0.65-1.43) in the multivariate regression analysis. In the sensitivity analyses after propensity-score matching, the hazard ratio for OS was 0.92 (95% CI, 0.58-1.45). Conclusions: Considering the hazard ratios and 95% CIs for OS, LG for scirrhous GC was not associated with worse survival than that for OG.

9.
Asian J Endosc Surg ; 14(1): 28-33, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32638531

ABSTRACT

INTRODUCTION: Appropriate dissection of the infrapyloric lymph nodes (no. 6 LNs) is important in gastric cancer surgery. In laparoscopic surgery, dissection of the no. 6 LNs along the inner dissectable layer from the left side of patient has been reported. However, it is difficult for surgeons to provide appropriate traction with their left hand from the left side. To resolve this difficulty, we dissected the no. 6 LNs from the patient's right side to identify the optimal layer. We then evaluated the oncologic reliability of the layer and the safety of this procedure. METHODS: From the patient's right side, the surgeon used their left hand to provide appropriate traction when pulling the adipose tissue, including the no. 6 LNs. This exposed the optimal layer between the adipose tissue and the pancreas. To assess this maneuver, the surgical outcomes of patients who underwent laparoscopic distal gastrectomy from April 2011 to March 2013 were retrospectively analyzed. The surgical outcomes included the number of the no. 6 LNs resected, time to dissect the no. 6 LNs, incidence of pancreatic complications, and recurrence in the no. 6 LNs. RESULTS: There were 112 patients identified. The median number of the no. 6 LNs resected was five. The median time to dissect the no. 6 LNs was 14 minutes. Four patients developed pancreatic fistula, and another four patients developed intra-abdominal abscess. There was no recurrence in the no. 6 LNs. CONCLUSION: The optimal layer was oncologically reliable, and these procedures were safe.


Subject(s)
Gastrectomy/methods , Laparoscopy , Lymph Node Excision/methods , Stomach Neoplasms , Traction/methods , Adult , Aged , Aged, 80 and over , Dissection/methods , Female , Humans , Lymph Nodes/surgery , Male , Middle Aged , Neoplasm Recurrence, Local , Reproducibility of Results , Retrospective Studies , Stomach Neoplasms/surgery
10.
Esophagus ; 16(3): 324-329, 2019 07.
Article in English | MEDLINE | ID: mdl-30945097

ABSTRACT

BACKGROUND: Effective treatment of esophageal cancer requires dissection of the regional lymph nodes (LNs) from the cervical to the abdominal area. In this study, we hypothesized that adequate no. 101R dissection is achieved through a thoracoscopic approach in the prone position. METHODS: The study cohort was limited to 42 patients who underwent thoracoscopic subtotal esophagectomy with bilateral cervical lymphadenectomy for thoracic esophageal cancer between January 2015 and March 2017. The number of LNs and the incidence of metastasis were analyzed. During the proposed thoracoscopic procedure, cervical paraesophageal LNs were dissected continuously, with the LNs surrounding the recurrent laryngeal nerve (RLN; no. 106rec) as an en bloc resection. In this study, LNs that required further picking up via a cervical incision were defined as no. 101. The recurrent sites among the consecutive patients during the 3-year follow-up, for whom bilateral cervical lymphadenectomy was omitted for lower and middle thoracic tumors between 2012 and 2014, were analyzed further. RESULTS: The data of 42 patients were analyzed. The lymphatic tissues dorsal to the right cervical RLN were almost completely dissected via thoracoscopy. A median of 0 (0-6) LNs were ventral to the right RLN (no. 101R) and no LN metastasis was observed. There were no lymph nodes in 27 patients (64%). By contrast, there was a median of 1(0-10) no. 101L nodes, and LN metastasis was observed in two patients (4.7%). The numbers of LNs at no. 106recR and no. 106recL were 3 (0-9) and 2(0-13), respectively, and the corresponding numbers of patients with metastases at these sites were 11(26%) and 5(12%), respectively. Among the 33 patients who completed the 3-year follow-up, 9 patients developed recurrence, but none involved 101R LNs. CONCLUSIONS: There were no residual LNs in the area ventral to the right cervical RLN in 64% of the patients who underwent additional cervical lymphadenectomy after the right thoracoscopic approach in the prone position. Further studies with larger patient cohort or randomization are required to confirm our results.


Subject(s)
Esophageal Neoplasms/pathology , Esophagectomy/methods , Lymph Node Excision/methods , Neck Dissection/methods , Thoracoscopy/methods , Aftercare , Aged , Esophageal Neoplasms/secondary , Esophageal Neoplasms/surgery , Esophagectomy/instrumentation , Female , Humans , Incidence , Lymph Node Excision/trends , Lymph Nodes/pathology , Lymph Nodes/surgery , Male , Middle Aged , Neoplasm Metastasis/pathology , Neoplasm Staging/methods , Prone Position , Recurrence , Recurrent Laryngeal Nerve/surgery , Retrospective Studies , Thoracic Neoplasms/pathology
11.
Int Cancer Conf J ; 7(4): 117-120, 2018 Oct.
Article in English | MEDLINE | ID: mdl-31149528

ABSTRACT

The fundamental principle of surgery for intestinal cancer is mesenteric excision. It has been widely accepted as radical surgery for colorectal cancer, and it comprises procedures such as complete mesocolic excision for colon cancer and total mesorectal excision for rectal cancer. So far, the concept of mesenteric excision of the esophagus has not been well documented, but our surgical experience with a magnified view using a thoracoscope and understanding of the surgical anatomy based on embryologic foregut development has led us to introduce the concept of mesotracheoesophagus. Using this concept, our technique is reproducible, effective, and safe for lymph node dissection along the left recurrent laryngeal nerve. Here we report our concept, procedure, and results of thoracoscopic esophageal cancer surgery.

12.
Surg Laparosc Endosc Percutan Tech ; 27(5): e101-e107, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28902037

ABSTRACT

PURPOSE: We evaluate surgical outcomes of intracorporeal esophagojejunostomy in laparoscopic total gastrectomy using 2 linear stapler methods. MATERIALS AND METHODS: The functional end-to-end anastomosis (FEEA) method was chosen as a first choice. The overlap method was chosen in cases with esophageal invasion. We retrospectively analyzed the early and late surgical outcomes of consecutive 168 laparoscopic total gastrectomy cases from April 2011 to December 2016. RESULTS AND CONCLUSIONS: The FEEA method was selected in 120 cases, and the overlap method was selected in 48 cases. The mean time of esophagojejunostomy for the FEEA and overlap method was 13.2 and 36.5 minutes, respectively. Two cases with FEEA method and 3 cases with overlap method experienced complications due to esophagojejunostomy leakage. These cases were treated without performing a reoperation. One case with FEEA method was complicated due to esophagojejunostomy stenosis. This case was endoscopically treated. Our procedures are safe and feasible.


Subject(s)
Esophagostomy/instrumentation , Gastrectomy/instrumentation , Jejunostomy/instrumentation , Laparoscopy/instrumentation , Stomach Neoplasms/surgery , Surgical Staplers , Aged , Anastomosis, Surgical/methods , Anastomotic Leak/etiology , Esophagostomy/methods , Feasibility Studies , Female , Gastrectomy/methods , Humans , Jejunostomy/methods , Laparoscopy/methods , Male , Operative Time , Surgical Stapling/instrumentation , Treatment Outcome
13.
Surg Endosc ; 31(8): 3398-3404, 2017 08.
Article in English | MEDLINE | ID: mdl-27924391

ABSTRACT

BACKGROUND: Wedge resection is the most commonly used method in laparoscopic partial gastrectomy for gastric gastrointestinal stromal tumor (GIST). However, this method can involve inadvertent resection of additional gastric tissue and cause gastric deformation. To minimize the volume of resected gastric tissue, we have developed a laparoscopic partial gastrectomy with seromyotomy which we call the 'lift-and-cut method' for gastric GIST. Here, we report a case series of this surgery. METHOD: First, the seromuscular layer around the tumor is cut. Because the mucosa and submucosa are extensible, the tumor is lifted toward the abdominal cavity. After sufficient lifting, the gastric tissue under the tumor is cut at the submucosal layer with a linear stapler (thus 'lift-and-cut method'). Finally, the defect in the seromuscular layer is closed with a hand-sewn suture. RESULTS: From April 2011 to December 2015, 28 patients underwent laparoscopic partial gastrectomy by this method at Osaka Red Cross Hospital. Average operation time was 126 min (range 65-302 min) and average blood loss was 10 ml (range 0-200 ml). No intraoperative complications including tumor rupture or postoperative complications regarded as Clavien-Dindo Grade II or higher occurred. All patients took sufficient solid diet at discharge. Median postoperative hospital stay was 7 days (range 5-21 days). On median follow-up of 26.6 months (range 6-54 months), no recurrence was reported. CONCLUSION: Laparoscopic partial gastrectomy by the lift-and-cut method is safe and simple, and widely applicable for gastric GIST.


Subject(s)
Gastrectomy/methods , Gastric Stump , Gastrointestinal Stromal Tumors/surgery , Laparoscopy/methods , Neoplasm Recurrence, Local/surgery , Stomach Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
14.
Surg Today ; 45(5): 549-58, 2015 May.
Article in English | MEDLINE | ID: mdl-24792009

ABSTRACT

Laparoscopic distal gastrectomy is an accepted option for gastric cancer surgery; however, laparoscopic total gastrectomy (LTG) is not widely performed. There is concern about the safety of the operation due to the difficulty of extracorporeal reconstruction through a mini-laparotomy. Efforts have been made to establish an intracorporeal anastomotic technique for esophagojejunostomy. This article reviews the current techniques available for laparoscopic esophagojejunostomy and their surgical outcomes. Several different techniques using either circular or linear staplers have been reported; however, the apparent superiority of any particular method has not been confirmed. The incidence of anastomosis-related complications varied among studies, but different techniques all successfully achieved excellent outcomes. The overall complication rate of LTG was similar to that of open total gastrectomy, suggesting that LTG is a safe and feasible option. However, the feasibility of LTG with D2 lymph node dissection for advanced upper gastric cancer needs to be confirmed in further studies, because most of the patients included in the LTG studies were diagnosed with early stages of disease.


Subject(s)
Anastomosis, Surgical/methods , Gastrectomy/methods , Laparoscopy/methods , Stomach Neoplasms/surgery , Esophagostomy/methods , Humans , Incidence , Jejunostomy/methods , Lymph Node Excision , Postoperative Complications/epidemiology , Surgical Staplers , Treatment Outcome
15.
J Laparoendosc Adv Surg Tech A ; 21(5): 387-91, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21561328

ABSTRACT

BACKGROUND: Totally laparoscopic distal gastrectomy (TLDG) has several advantages over laparoscopic-assisted distal gastrectomy (LADG), including a shorter incision, less pain, and earlier recovery. We compared the feasibility and early surgical outcomes of TLDG and LADG in patients with gastric cancer. METHODS: Between September 2008 and December 2009, 180 patients with gastric cancer underwent TLDG with intracorporeal gastroduodenostomy using linear staplers; and between January 2006 and December 2009, 268 patients with gastric cancer underwent LADG with extracorporeal gastroduodenostomy using circular staplers. Clinical features and early surgical outcomes were compared between the two groups. RESULTS: There were no between-group differences in postoperative clinical course and complications. Postoperative pain and the amount of pain killer administered were significantly lower (P<.05 each), and postoperative scars were smaller in the TLDG group. CONCLUSIONS: TLDG with intracorporeal gastroduodenostomy is as safe and feasible as LADG for patients with gastric cancer. Moreover, TLDG is less invasive and more comfortable for patients than LADG.


Subject(s)
Duodenostomy/methods , Gastrectomy/methods , Gastroenterostomy/methods , Laparoscopy , Stomach Neoplasms/surgery , Feasibility Studies , Female , Humans , Male , Middle Aged , Time Factors , Treatment Outcome
16.
Gastric Cancer ; 14(4): 365-71, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21573920

ABSTRACT

BACKGROUND: We developed a new method of intracorporeal gastroduodenostomy, the delta-shaped anastomosis, in which only endoscopic linear staplers are used. In this report, we present the short- and long-term outcomes of our initial experience with this procedure. METHODS: We retrospectively analyzed 100 consecutive gastric cancer patients who underwent the delta-shaped anastomosis procedure from May 2001 to November 2006. All of them underwent a laparoscopic distal gastrectomy with regional lymph node dissection. Quality of life was assessed with a questionnaire 6 months or more postoperatively, and the gastric remnant was evaluated by endoscopy one year following the surgery. RESULTS: Eight surgeons successfully performed the delta-shaped anastomosis without any conversion to laparotomy. The learning curve for all surgeons was steep and the mean time for the anastomosis was 13 min. Only one patient developed an anastomotic leak, and the leak was minor. Sixty-five patients tolerated a 1500 kcal/day soft diet at the time of discharge. The mean follow-up period was 54.9 months. Only one patient reported symptoms indicative of dumping. Two patients were diagnosed with reflux esophagitis, and approximately 70% had evidence of bile reflux, but severe gastritis of the remnant stomach on endoscopy was uncommon. CONCLUSIONS: The wide lumen of the delta-shaped anastomosis led to early, adequate postoperative oral intake without a significant incidence of dumping syndrome. The delta-shaped anastomosis is safe and simple and provides satisfactory postoperative results.


Subject(s)
Duodenum/surgery , Gastroenterostomy/methods , Stomach Neoplasms/surgery , Aged , Bile Reflux/etiology , Diet , Dumping Syndrome/etiology , Female , Follow-Up Studies , Gastrectomy/methods , Gastroenterostomy/adverse effects , Humans , Laparoscopy/methods , Lymph Node Excision , Male , Middle Aged , Quality of Life , Retrospective Studies , Stomach/surgery , Sutures , Treatment Outcome
17.
Surg Endosc ; 25(4): 1076-82, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20835726

ABSTRACT

OBJECTIVE: To evaluate the effectiveness of totally laparoscopic distal gastrectomy with gastroduodenostomy (TLDG), we compared its early surgical outcomes with those of laparoscopy-assisted distal gastrectomy with gastroduodenostomy (LADG). METHODS: We retrospectively analyzed early surgical outcomes in 567 patients who underwent laparoscopic gastrectomy for gastric cancer between January 2009 and March 2010. The patients were divided into those with underwent TLDG and those with underwent LADG. Their surgical outcomes were analyzed according to the WHO Asia-Pacific Obesity classification. RESULTS: In overall patients, TLDG showed the significant results of early surgical outcomes. But more importantly, in the analysis of early surgical outcomes for obese patients, we found that TLDG could improve overall complication rate (p = 0.031), time to first flatus (p = 0.009), time to commencement of soft diet (p < 0.001), administration of analgesics (p = 0.019), pain score (Numeric Rating Scale, NRS), and hospital discharge (p = 0.003). CONCLUSIONS: We suggested that TLDG contributes to the improvement of early surgical outcomes. We further suggest that TLDG in obese patients could be the best way to improve early surgical outcomes, including the bowel movement, pain score, overall complication rate, and hospital discharge.


Subject(s)
Duodenum/surgery , Gastrectomy/methods , Gastroenterostomy/methods , Laparoscopy/methods , Obesity/complications , Postoperative Complications/prevention & control , Stomach Neoplasms/surgery , Adult , Aged , Body Mass Index , Female , Humans , Length of Stay/statistics & numerical data , Lymph Node Excision/methods , Male , Middle Aged , Pain, Postoperative/epidemiology , Pain, Postoperative/prevention & control , Postoperative Complications/epidemiology , Recovery of Function , Retrospective Studies , Stomach Neoplasms/complications , Thinness/complications , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...